Curis Lifesciences Limited (NSE:CURIS)

Market Cap	905.46M
Revenue (ttm)	606.29M +155.3%
Net Income	69.16M +1,304.6%
EPS	10.26 +1,046.0%
Shares Out	8.08M
PE Ratio	10.92
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Open	112.00
Previous Close	109.00
Day's Range	112.00 - 112.00
52-Week Range	83.60 - 147.90
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 22, 2026

About Curis Lifesciences

Curis Lifesciences Limited operates as a pharmaceutical manufacturer, specializing in manufacturing of a wide range of pharmaceutical products, such as tablets, capsules, external preparations, oral liquid, and sterile ophthalmic ointments in India. The company's business model operates through loan license manufacturing, through which, the company carry outs manufacturing under Loan License arrangement for domestic suppliers, where all raw materials and excipients are procured and delivered by the client; contract manufacturing, where the comp...

• Industry: Commercial Physical and Biological Research
• Founded: 2010
• Country: India
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: CURIS

Financial Performance

In fiscal year 2026, Curis Lifesciences's revenue was 606.29 million, an increase of 22.16% compared to the previous year's 496.32 million. Earnings were 69.16 million, an increase of 13.29%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 21, 2026

Data Sources Report a data error